Icosapent sodium

Base Information

• Chemical Name: Icosapent sodium
• CAS No.: 73167-03-0
• Molecular Formula: C20H30 O2 . Na
• Molecular Weight: 302.45
• UNII: 5PXN91KPRO
• Nikkaji Number: J712.015J
• Wikidata: Q27262719
• Mol file: 73167-03-0.mol

Synonyms:Icosapent sodium;73167-03-0;Sodium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate;Eicosapentaenoic Acid (sodium salt);UNII-5PXN91KPRO;5PXN91KPRO;Eicosapentaenoic Acid (sodium);5,8,11,14,17-Eicosapentaenoic acid, sodium salt, (all-z)-;sodium;(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate;5,8,11,14,17-Eicosapentaenoic acid, sodium salt (1:1), (5Z,8Z,11Z,14Z,17Z)-;cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt;5Z,8Z,11Z,14Z,17Z-eicosapentaenoicacid,monosodiumsalt;eicosapentaenoic acid sodium salt;CS-W011985;HY-W011269;AS-69485;Q27262719;(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Icosapentaenoic acid sodium salt;5,8,11,14,17-Eicosapentaenoicacid,sodium salt(1:1),(5Z,8Z,11Z,14Z,17Z)-

Chemical Property of Icosapent sodium

Chemical Property:

• Vapor Pressure: 6.04E-09mmHg at 25°C
• Melting Point: −54-−53 °C(lit.)
• Refractive Index: n20/D 1.4977(lit.)
• Boiling Point: 439.3°C at 760 mmHg
• Flash Point: 336°C
• PSA: 40.13000
• Density: 0.943 g/mL at 25 °C(lit.)
• LogP: 4.65800
• Storage Temp.: −20°C
• Hydrogen Bond Donor Count: 0
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 13
• Exact Mass: 324.20652445
• Heavy Atom Count: 23
• Complexity: 404

Purity/Quality:

98%,99%, ^*data from raw suppliers

cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt ≥99% (capillary GC) ^*data from reagent suppliers

Safty Information:

• Hazard Codes: C
• Statements: 34
• Safety Statements: 26-36/37/39-45

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CCC=CCC=CCC=CCC=CCC=CCCCC(=O)[O-].[Na+]
• Isomeric SMILES: CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-].[Na+]
• Uses: reduces thromboxane A2 production and platelet aggregation, inhibits 5-lipoxygenase and prevents arteriosclerosis. cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt has been used:to study its effect on the pathology of lupus in drug-induced and spontaneous mouse modelsto pretreat mouse alveolar macrophages to study the effect/relationship between amiodarone and eicosapentaenoic acid (EPA) concerning the cytokine releaseto examine if pharmacological correction with EPA supplementation might restore autophagic flux and reduce renal lipotoxicity in mice